FC
SBRA icon

Farringdon Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Farringdon Capital’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,376
Closed -$529K – 625
2025
Q3 		$529K Buy
+28,376
New +$530K 0.13% 231

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Farringdon Capital's SBRA Position: Q4 2025 in Review

Farringdon Capital sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 28,376 shares — an estimated $529K sold.

Farringdon Capital first reported a position in SBRA in Q3 2025 and held it in 1 quarter. The position peaked at $529K in Q3 2025. 439 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Farringdon Capital reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Farringdon Capital sold 28,376 Sabra Healthcare REIT shares in Q4 2025, an estimated $529K.
  • Farringdon Capital first reported a position in Sabra Healthcare REIT in Q3 2025 and held it in 1 quarter.
  • Farringdon Capital's Sabra Healthcare REIT position peaked at $529K in Q3 2025.
  • 439 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.